Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

α-Methylacyl-CoA racemase spliced variants and their expression in normal and malignant prostate tissues.

Ouyang B, Leung YK, Wang V, Chung E, Levin L, Bracken B, Cheng L, Ho SM.

Urology. 2011 Jan;77(1):249.e1-7. doi: 10.1016/j.urology.2010.08.005.

2.

Alternative spliced variants of the alpha-methylacyl-CoA racemase gene and their expression in prostate cancer.

Mubiru JN, Shen-Ong GL, Valente AJ, Troyer DA.

Gene. 2004 Feb 18;327(1):89-98.

PMID:
14960364
3.

alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.

Rubin MA, Zhou M, Dhanasekaran SM, Varambally S, Barrette TR, Sanda MG, Pienta KJ, Ghosh D, Chinnaiyan AM.

JAMA. 2002 Apr 3;287(13):1662-70.

PMID:
11926890
4.

Kinetic fluorescence reverse transcriptase-polymerase chain reaction for alpha-methylacyl CoA racemase distinguishes prostate cancer from benign lesions.

Schostak M, Miller K, Krause H, Schrader M, Kempkensteffen C, Kollermann J.

Cancer Detect Prev. 2006;30(5):449-54. Epub 2006 Oct 25.

PMID:
17067752
5.

Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.

Luo J, Zha S, Gage WR, Dunn TA, Hicks JL, Bennett CJ, Ewing CM, Platz EA, Ferdinandusse S, Wanders RJ, Trent JM, Isaacs WB, De Marzo AM.

Cancer Res. 2002 Apr 15;62(8):2220-6.

6.
7.

Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk.

Zheng SL, Chang BL, Faith DA, Johnson JR, Isaacs SD, Hawkins GA, Turner A, Wiley KE, Bleecker ER, Walsh PC, Meyers DA, Isaacs WB, Xu J.

Cancer Res. 2002 Nov 15;62(22):6485-8.

8.

Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker.

Jiang Z, Wu CL, Woda BA, Iczkowski KA, Chu PG, Tretiakova MS, Young RH, Weiss LM, Blute RD Jr, Brendler CB, Krausz T, Xu JC, Rock KL, Amin MB, Yang XJ.

Histopathology. 2004 Sep;45(3):218-25.

PMID:
15330799
9.
10.
11.

Branched fatty acids in dairy and beef products markedly enhance alpha-methylacyl-CoA racemase expression in prostate cancer cells in vitro.

Mobley JA, Leav I, Zielie P, Wotkowitz C, Evans J, Lam YW, L'Esperance BS, Jiang Z, Ho SM.

Cancer Epidemiol Biomarkers Prev. 2003 Aug;12(8):775-83.

13.

A-methylacyl-CoA racemase (AMACR) and prostate-cancer risk: a meta-analysis of 4,385 participants.

Jiang N, Zhu S, Chen J, Niu Y, Zhou L.

PLoS One. 2013 Oct 9;8(10):e74386. doi: 10.1371/journal.pone.0074386. eCollection 2013.

14.

alpha-Methylacyl-CoA racemase: expression levels of this novel cancer biomarker depend on tumor differentiation.

Kuefer R, Varambally S, Zhou M, Lucas PC, Loeffler M, Wolter H, Mattfeldt T, Hautmann RE, Gschwend JE, Barrette TR, Dunn RL, Chinnaiyan AM, Rubin MA.

Am J Pathol. 2002 Sep;161(3):841-8.

15.

Elevated alpha-methylacyl-CoA racemase enzymatic activity in prostate cancer.

Kumar-Sinha C, Shah RB, Laxman B, Tomlins SA, Harwood J, Schmitz W, Conzelmann E, Sanda MG, Wei JT, Rubin MA, Chinnaiyan AM.

Am J Pathol. 2004 Mar;164(3):787-93.

16.
17.

Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer.

Zha S, Ferdinandusse S, Denis S, Wanders RJ, Ewing CM, Luo J, De Marzo AM, Isaacs WB.

Cancer Res. 2003 Nov 1;63(21):7365-76.

18.

Alpha-Methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions.

Zhou M, Chinnaiyan AM, Kleer CG, Lucas PC, Rubin MA.

Am J Surg Pathol. 2002 Jul;26(7):926-31.

PMID:
12131161
19.

Detection of alpha-methylacyl-coenzyme-A racemase transcripts in blood and urine samples of prostate cancer patients.

Zehentner BK, Secrist H, Zhang X, Hayes DC, Ostenson R, Goodman G, Xu J, Kiviat M, Kiviat N, Persing DH, Houghton RL.

Mol Diagn Ther. 2006;10(6):397-403.

PMID:
17154657

Supplemental Content

Support Center